Boothbay Fund Management’s Disc Medicine IRON Stock Holding History

Boothbay Fund Management’s Portfolio IRON Stock Details IRON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-21,378	Closed	-$1.47M	–	2435
2026 Q1	$1.37M	Buy	+21,378	New	+$1.48M	0.02%	796
2024 Q2	–	Sell	-6,759	Closed	-$421K	–	1697
2024 Q1	$421K	Sell	6,759 -36,391	-84%	-$2.36M	0.01%	1066
2023 Q4	$2.49M	Buy	43,150 +11,864	+38%	+$607K	0.06%	405
2023 Q3	$1.47M	Sell	31,286 -17,655	-36%	-$883K	0.03%	605
2023 Q2	$2.17M	Buy	+48,941	New	+$1.74M	0.05%	527
2022 Q3	–	Sell	-1,410	Closed	-$71K	–	2412
2022 Q2	$71K	Hold	1,410	–	–	﹤0.01%	2042
2022 Q1	$59K	Hold	1,410	–	–	﹤0.01%	2162
2021 Q4	$123K	Hold	1,410	–	–	﹤0.01%	1670
2021 Q3	$171K	Sell	1,410 -180	-11%	-$24.6K	﹤0.01%	1633
2021 Q2	$309K	Sell	1,590 -962	-38%	-$316K	0.01%	1258
2021 Q1	$1.04M	Buy	+2,552	New	+$1.14M	0.04%	579

Other funds holding IRON

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

VPC

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

AVLSA

Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Boothbay Fund Management's IRON Position: Q2 2026 in Review

Boothbay Fund Management sold out of Disc Medicine (IRON) in Q2 2026, closing a stake of 21,378 shares — an estimated $1.47M sold.

Boothbay Fund Management first reported a position in IRON in Q1 2021 and held it in 11 quarters. The position peaked at $2.49M in Q4 2023. 216 funds tracked by Wall St. Rank hold IRON as of Q2 2026.

Boothbay Fund Management reported no remaining Disc Medicine position as of Q2 2026 after selling out during the quarter.
Boothbay Fund Management sold 21,378 Disc Medicine shares in Q2 2026, an estimated $1.47M.
Boothbay Fund Management first reported a position in Disc Medicine in Q1 2021 and held it in 11 quarters.
Boothbay Fund Management's Disc Medicine position peaked at $2.49M in Q4 2023.
216 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2026.

Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.